GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Sanofi-aventis Sa (SNY) [hlAlert]

Sanofi-Aventis is a pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. The Company's business includes two main activities: pharmaceuticals and human vaccines through sanofi pasteur. In its pharmaceutical activity, Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular,
metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. On September 1, 2008, Sanofi-Aventis acquired the Australian company, Symbion CP Holdings Pty Ltd (Symbion Consumer). On September 25, 2008, it acquired Acambis plc. In January 2009, the Company sold its French plant of Colomiers to French pharmaceutical company Unither. In April 2009, the Company acquired Mexican generic company, Laboratorios Kendrick.
.
( Total: 17 Current Stock Recommendations )
Sanofi-aventis Sa   (17)
Hold 47% Buy 53%
Related companies
Allergan, Inc.   (30)
Hold 40% Buy 60%
Novo Nordisk A/s   (18)
Sell 17% Hold 44% Buy 39%
Amgen Inc.   (30)
Hold 47% Buy 53%
Gilead Sciences, ...   (48)
Sell Hold 15% Buy 81%
Teva Pharmaceutical ...   (41)
Hold 27% Buy 73%
Celgene Corporation   (44)
Sell Hold Buy 84%
Allergan Plc   (28)
Hold 29% Buy 71%
Biogen Idec Inc   (41)
Sell Hold 27% Buy 68%
Filter by Gains:   
  
Rating:
Hold SNY
down 11.54 %

Rating:
Buy SNY
down 11.54 %
Sanofi-aventis Sa (SNY) rated Overweight by Morgan Stanley
Thursday,  Oct 15, 2015  10:25 AM ET

Rating:
Hold SNY
up 48.20 %
Sanofi-aventis Sa (SNY) downgraded to Neutral by JP Morgan
Monday,  Jan 6, 2014  8:25 AM ET

Rating:
Buy SNY
down 7.85 %
Sanofi-aventis Sa (SNY) rated Buy by Kepler
Monday,  Nov 18, 2013  9:25 AM ET

Rating:
Hold SNY
Sanofi-aventis Sa (SNY) rated Mkt Perform by Leerink Swann
Friday,  Oct 18, 2013  8:25 AM ET

Rating:
Buy SNY
down 3.89 %
Sanofi-aventis Sa (SNY) rated Buy by Berenberg
Wednesday,  Aug 7, 2013  8:25 AM ET

Rating:
Hold SNY
Sanofi-aventis Sa (SNY) rated Neutral by Natixis Bleichroeder
Thursday,  Aug 1, 2013  8:25 AM ET

Rating:
Buy SNY
up 43.74 %
Barron's Favorite Stocks for 2012 - Sanofi
Thursday,  Jan 3, 2013  1:23 AM ET

Rating:
Buy SNY
up 7.26 %
Sanofi-aventis Sa (SNY) upgraded to Buy by Jefferies
Friday,  Dec 14, 2012  8:25 AM ET

Rating:
Buy SNY
up 19.29 %
Sanofi-aventis Sa (SNY) rated Buy by BofA/Merrill
Monday,  Sep 10, 2012  8:25 AM ET

Rating:
Hold SNY
Sanofi-aventis Sa (SNY) rated Hold by Standpoint Research
Friday,  Aug 3, 2012  2:25 PM ET

Rating:
Hold SNY
Sanofi-aventis Sa (SNY) rated Hold by Jefferies
Tuesday,  Jan 11, 2011  8:25 AM ET

Rating:
Buy SNY
up 29.97 %
Sanofi-aventis Sa (SNY) rated Buy by Deutsche Securities
Monday,  Nov 16, 2009  8:25 AM ET

Rating:
Hold SNY
down 26.51 %
Sanofi-aventis Sa (SNY) upgraded to Neutral by UBS
Wednesday,  Oct 14, 2009  8:25 AM ET

Rating:
Buy SNY
up 48.20 %
Sanofi-aventis Sa (SNY) upgraded to Overweight by JP Morgan
Friday,  Aug 28, 2009  8:25 AM ET

Your Recent Stocks
SymbolLastChange
SNY 40.32 down  -19.48 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy